U.S. Cannabis Market Size To Reach $40.10 Billion By 2030

June 2024 | Report Format: Electronic (PDF)

U.S. Cannabis Market Growth & Trends

The U.S. cannabis market size is expected to reach USD 40.10 billion by 2030, registering a CAGR of 13.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as legalization of medicinal cannabis, growing consumer disposable income, rising demand for cannabis from the pharmaceutical industry, growing consumer awareness of the health benefits of cannabis, presence of major manufacturers, and the approval of the U.S. farm bill are expected to boost the market growth.

Cannabis is generally used for the treatment of various conditions, such as cancer, mental disorders, pain management, & nausea, and for recreational purposes. The high prevalence of cancer is expected to be one of the factors driving the adoption of medical marijuana over the forecast period. For instance, according to an article published by the American Cancer Society in January 2023, 609,820 cancer deaths and 1,958,310 new cancer cases were anticipated to occur in the U.S. In addition to that, two cannabidiol (CBD) drugs namely nabilone and dronabinol are approved by the FDA for the treatment of vomiting and nausea caused by chemotherapy in the U.S.

Furthermore, rising awareness among people regarding the therapeutic benefits of cannabis and the launch of cannabis certification programs through partnerships drives market growth. For instance, in December 2023, Bellarmine University introduced a cannabis education certificate program offered by a public Kentucky University focusing on agriculture, business, medicine, and law in the fast-changing cannabis industry.

With the legalization of cannabis in different areas of the U.S. for medical & recreational use, many well-known personalities and mainstream companies are seeking to benefit from this trend. For instance, celebrities such as Jay-Z and Snoop Dogg have joined this movement by launching branded cannabis products (Monogram). However, avid cannabis consumers seek information regarding the extent of the celebrity’s involvement in the cultivation process. Despite this scrutiny, more celebrities are expected to follow this trend and enter the cannabis cultivation industry.

Moreover, new technologies and improvements are continually being developed for the cultivation of cannabis. With an increasing demand for technologically advanced cannabis production, these expanded techniques are anticipated to assist cultivators in optimizing their resources, which further drives the market growth.


key Request a free sample copy or view report summary: U.S. Cannabis Market Report


U.S. Cannabis Market Report Highlights

  • Based on source, the marijuana segment accounted for the largest revenue share in 2023 due to the recognition of cannabis for medical purposes and the increasing legalization of its use

  • Based on derivative, the CBD segment dominated the market with the largest revenue share in 2023, owing to growing acceptance and a rise in demand for CBD-infused food, cosmetics, and medication

  • Based on end-use, the medical use segment held the largest revenue share in 2023 due to the increasing research activity and growing clinical trials supporting its benefits in treating various chronic diseases

U.S. Cannabis Market Segmentation

Grand View Research, Inc. has segmented the U.S. cannabis market based on source, derivatives, and end-use:

U.S. Cannabis Source Outlook (Revenue, USD Million, 2018 - 2030)

  • Hemp

    • Hemp Oil

    • Industrial Hemp

  • Marijuana

    • Flower

    • Oil and Tinctures

U.S. Cannabis Derivative Outlook (Revenue, USD Million, 2018 - 2030)

  • CBD

  • THC

  • Others

U.S. Cannabis End-use Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Industrial Use

  • Medical Use

    • Chronic Pain

    • Depression and Anxiety

    • Arthritis

    • Post Traumatic Stress Disorder (PTSD)

    • Cancer

    • Migraines

    • Epilepsy

    • Alzheimer’s Disease

    • Multiple Sclerosis

    • AIDS

    • Amyotrophic Lateral Sclerosis

    • Tourette’s Syndrome

    • Diabetes

    • Parkinson's Disease

    • Glaucoma

    • Others

  • Recreational Use

List of Key Players in the U.S. Cannabis Market

  • Medical Marijuana, Inc.

  • NuLeaf Naturals, LLC

  • CV Sciences, Inc.

  • CHARLOTTE’S WEB.

  • The Cronos Group

  • Organigram Holding, Inc.

  • Irwin Naturals

  • Tilray Brands

  • Canopy Growth Corporation

  • Aurora Cannabis

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.